A B S T R A C T Quinine-or quinidine-induced thrombocytopenic purpura is caused by synthesis of an immunoglobulin (Ig)G antibody, which causes platelet damage in the presence of the offending drug. The nature of the antigenic stimulus has been examined by measuring incorporation of [3H]thymidine into DNA during lymphocyte transformation to blast cells in the presence of the drug. Although patients' lymphocytes responded normally to the nonspecific mitogen, phytohemagglutinin P, they did not respond to either drug or platelets alone. However, significant transformation occurred when patients' lymphocytes were cultured for 7 d with homologous or autologous platelets in the presence of therapeutic concentrations of the drugs (0.39-39 ,M). Platelet membranes were more active than intact platelets on the basis of protein content, whereas platelets from a patient with Bernard-Soulier syndrome were inactive. Washed platelets pretreated with the drugs were inactive when cultured with lymphocytes in the absence of the drugs, whereas platelets pretreated similarly in plasma caused transformation. Control lymphocytes from 20 normal patients and 6 patients with nondrug-induced thrombocytopenia were not transformed by drugs and platelets in the presence of normal serum or serum containing drug-dependent antibody, showing that the observed response was specific for presensitized lymphocytes. Thus lymphocytes of patients with drug-induced thrombocytopenia are transformed by an antigen that forms after interaction ofplasma, specific platelet membrane components and the drug.
INTRODUCTION
In thrombocytopenia induced by various drugs immunoglobulin (Ig)G antibodies have been shown to cause platelet damage in the presence of the offending drug (1) . Formation of an antigen-antibody complex evidenced by complement fixation only occurs in the presence of drug, antibody and platelet (2, 3) . Two hypotheses have been postulated to explain the pathology of the disorder. Ackroyd (1) suggested that the drug reacts with platelets to form a complex which acts as antigen for antibody synthesis. However, synthesis of antibodies against the drug alone and subsequent nonspecific interaction of the resulting immune complex with platelets which act as "innocent bystanders" have been favored by others (4, 5) .
We have attempted to differentiate between these two possibilities by examining directly the antigenic stimulus for antibody synthesis in vitro. Since presensitized lymphocytes are transformed when exposed to the appropriate antigen (6, 7) we have investigated the substances required to transform lymphocytes from patients with quinine or quinidine-induced thrombocytopenia by measuring incorporation ofradioactive thymidine into DNA in cell cultures. We report here that the drug, plasma components and platelets interact to form material able to transform patients' lymphocytes.
METHODS
Clinical material. Hospitalized patients fulfilling the diagnostic criteria of acute quinine-or quinidine-induced thrombocytopenic purpura (1) were studied. Sera of all patients were positive in the tests for detection of drug-dependent antibodies. Six patients had developed purpura more than 6 mo before this study, and were in remission; the remaining six had presented recently and were on prednisolone therapy when studied. 10 control patients were studied. Six with idiopathic thrombocytopenic purpura were examined. Three of these had beeni previously exposed to quinine or quinidine but their thrombocytopenia was unrelated to drug ingestioni and the laboratory test for drug-dependent antibody was negative.
All but one were taking prednisolone, and three had had splenectomy. Others examined included a patient vith chronic obstructive airways disease who was given quinine for nocturnal cramps, a patient with cardiac arrhythmia, treated with quinidine, and two healthy volunteers who ingested (quinine (1.8 g daily for 3 d). None developed thrombocytopenia.
20 healthy blood donors who had no history of drug sensitivity were also investigated. Blood from a patient fulfilling the classic criteria of Bernard-Soulier syndrome (8) was kindlyr supplied by Dr Lyminphocyte isolation. Venous blood anticoagulated with 4 U heparin/ml was centrifuged at 120 g for 20 min. The sediment was centrifuged at 1,300 g for 10 min and the buffy coat suspenided in Hanks' balanced salt solution. Lymphocytes were isolated by the method of Boyum (9) by layering the buffy coat on a Ficoll-Hypaque gradient with a final density of 1.077 g/ml. After centrifugation at 800 g for 25 min the lymphocyte-rich interface was removed and washed twice with Hanks' balanced salt solution, the cell pellet was suspended in MENIM, incubated at 37°C for 1 h in a 5% C02/air mixture, washed once, and resuspended in MEM. This suspension was supplemented with 100 U penicillin and 100 ,g streptomiiycin/nml. Cell viability, as determined by trypan blue exclusion was >98%. The final cell count was adjusted to 0.625 x 10 cells/ml.
Macrophage-depleted lymphocyte suspensions were obtained by incubating the twice washed lymphocyte pellet after Ficoll-Hypaque centrifugation in MEM that contained 5% fetal calf serum and carbonyl iron (1 mg/ml) for 30 min at 37°C (10) . The cell suspension was centrifuged again on a Ficoll-Hypaque gradient, washed, incubated, and resuspended as described above.
Platelet-rich plasmia (PRP) . Venous 
RESULTS
Transformation of patients' lymphocyltes in the presence of platelets and drugs. The effects of including the potentially antigenic substances quinine, quinidine, and/or platelets in cultures of lymphocytes from 10 patients with drug-induced thrombocytopenia were investigated. The drugs were tested at 0.39-390
,uM since this range encompasses both the levels occurring in vivo during their therapeutic ingestion (17) and in in vitro tests to detect the antibody. No significant [3H]TdR incorporation was seen in the presence either of drug alone at any concentration (151±48 cpm) or of autologous platelets alone (124±+-54 cpm), compared with cultures to which saline was added (120+90 cpm). For the sake of clarity, subsequent results are expressed as net counts per minute in excess of those incorporated into appropriate control cultures containing washed platelets alone. In the presence of both platelets and drug, significant lymphocyte stimulation was seen, and this was greatest after 7 d culture. A representative result is shown in Fig. 1 .
In the 7-d lymphocyte cutltuires of six other patients [3H]TdR incorporation was highest at drug concentrations between 3.9-39 ,uM and did not occur in the absence of platelets (Fig. 2) . A summary of the results obtained for both patients and controls are presented in Table I . Quinidine caused less, but significant, [3H]-TdR incorporation than quinine into lymphocytes from patients with quinine-induced thrombocytopenia, and similarly quinine was less effective where the thrombocytopenia was caused by quinidine ingestion. Platelets from both the patients and from normal donors caused
[3H]TdR incorporation although autologous platelets were approximately twice as effective. Lymphocytes from patients with idiopathic thrombocytopenia were not transformed by platelets and either of the drugs. Similar patients who had ingested either quinine or (juinidine but who did not have a drug-dependent antibody were also not significantly transformed by platelets and either drug. Lymphocytes from two other hospitalized donors and from two normal volunteers who had ingested quinine were not transformed by either drug. The reduced capacity of the lymphocytes of all patient groups to be transformed by PHA and the large range of response was probably a result of many of the patients receivinig steroid therapy. Lymphocytes from 20 normal donors showed normal transformation by PHA, but were not transformed by platelets and either drug.
Since the patients' lymphocytes consistently showed little transformation by the drugs at concentrations higher than 39 ,uM, the contributioni of reported inhibitory effects of the drugs on the lymphocytes (18, 19) When platelets were fractionated and either the 100,000 g membrane pellet or supernate were used instead of platelets in the presence of drugs in cultured lymphocytes from patients, transforming activity was seen to reside in the membrane fraction (Table III) . On the basis of protein content the membranes were more effective than intact platelets. Membranes from erythrocytes could not replace platelet membranes at any concentration tested (1-2.5 times the protein content of platelets or platelet membranes).
Activity of platelets froml a patienit wcith BerntardSoulier syndromiie. Replacement of normal platelets by those from a patient with Bernard-Soulier syndromiie in the presence of 39 ,uM quinidine caused [3H]TdR incorporation of only 7 cpm in cultures of lymphocytes from a patient sensitive to quinidine, while normal platelets caused incorporation of 1,190 cpm.
Requirement of a plasma compontetnt for formiiationi of the antigenic stimnulus. To examine the possible role of plasma components in the cultures in forming an antigenic stimulus in the presence of the drug both normal and patients' PRP were pretreated with the drugs, as described in Methods, the platelets washed and included in cultures of patients' lymphocytes. Such drug pretreated platelets were able to cause significant transformation in cultures of patients' lymphocytes in the absence of added drug (Table IV ) similar to that caused by saline pretreated platelets cultured in the presence of the drug. Thus formation of a stable antigenic stimulus results from incubation of the drug, plasma, and platelets. Both normal and patients' pretreated PRP appeared equally effective.
DISCUSSION
The results presented here show that lymphocytes of patients with quinine-or quinidine-induced thrombocytopenic purpura, but not those of either normal blood donors or other thrombocytopenic patients, are tranisformed by an antigenic stimulus formed by one of these drugs and components from both platelet membranes and plasma.
The requirement for several components to induce lymphocyte transformation differs from results of investigations of other thrombocytopenias; in digitoxininduced thrombocytopenic purpura, patients' lymphocytes could be transformed by the drug alone (20) . Platelets from patients with idiopathic thromnbocytopenia have been reported to cause transformationi of their own lymphocytes (21, 22) . In our experimeints no significant increase in [3H]TdR incorporation was observed by the addition of platelets alone to cultures of lymphocytes from either patients with drug-induced thrombocytopenia or with idiopathic thrombocytopenia. Our failure to observe transformation of lymphocytes from patients with idiopathic thrombocytopenia may be due to our use of low platelet/lymphocyte ratios (0.02:1).
The simplest explanation of our results with patienits In other inistanices where a hapteni re(quires a larger molecular carrier for lymphocyte stimulationi, the IgG antibody is usually directed specifically towards the hapten and not a combinatioin of the two (24) . Yet detectioin of (quinine-or quinidine-dependent antibodies by platelet damage or by complemiient fixation (3) reqtuires both platelet and drug. We have found that, whereas platelets and the drug together cause transformation of patients' lymphocytes in cultures which contain serum, simple pretreatment of platelets with the drug did not render them antigenic; rather, plasma was needed during this pretreatment. Three possibilities exist to explain these observations: (a) only in the presence of plasma components does a sufficient amount of the drug become firmly associated with the platelets to cause transformation by a drug/platelet antigen in lymphocyte cultures, (b) a plasma component and the drug might combine with the platelet membrane to form a more complex antigen, or (c) the drug and plasma component might alter the platelet membrane in a specific way to form a completely new antigen. It seems unlikely that the antigen is anl altered form of either a plasma component or the drug alone since the lymphocyte-transforming principle remains associated with the platelets.
That the sites on the platelet surface involved in antigeni productioin are specific is suggested by the capacity of membranes from platelets, but not from erythrocytes, to replace whole platelets in inducing lymphocyte transformation and by the lack of this capacity in platelets from a patient with BernardSoulier syndrome. Kunicki et al. (25) have shown that An1tigenlic Stimtiltis in Drtig-intdtuced Thromboct topetnia platelets with the membrane defect of Bernard-Soulier syndrome lack the receptor with which drug-dependent antibodies react. As the major abnormality of these platelets is a deficiency of two glycoproteins (termed GPIb and glycocalicin) (26), our results might suggest that one of the glycoproteins actually comprises part of the antigen to which the antibodies are formed rather than acting only as a receptor for attachment of a drug-antibody complex.
Earlier studies have indicated considerable specificity of the antibodies towards the isomers, quinine and (quinidine; in only 20% of patients could the stereoisomer react with the antibody to cause platelet damage (27) and the antibodies of the patients in our study also showed clear specificity. However, lymphocytes of the patients showed the ability to be transformed by the isomer to almost half the level of that obtained with the drug to which the patient was sensitive. This may be a result of measuring [3H]TdR incorporation into DNA rather than specific antibody synthesis.
In view of our findings it woul(d appear that in the phenomen-on of drug-induced thrombocytopenic purpura the platelet is more than ain innocenit bystander that is attacked by a drug-antibody complex, as suggested by Shulman (4, 5) . Our results rather favor the early hypothesis by Ackroyd (1) , who suggested that the interaction of the drug and platelets generates an antigenic complex. However, Shulman also has suggested that a plasma component with a special affinity for the platelet membrane may react with the drug (5) and indeed we have shown that a plasma or serum component is required for the formationi of the antigen.
This study thus provides direct evidence for the nature of the antigenic stimulus for (uinine-and quinidine-dependent thrombocytopenia. The manner in which specific platelet membrane components, the drug and a plasma substance interact to form an antigen capable of inducing transformation of lymphocytes from sensitive patients is a subject for further study.
